Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Reviews Neurology

• Publication date

  2018-01-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrneurol.2017.188PMID 29377008PMCID PMC5829048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart rate variability in normal tension glaucoma

  2018cited by this paper
• Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan–Herndon–Dudley Syndrome

  2017cited by this paper
• Interstitial solute transport in 3D reconstructed neuropil occurs by diffusion rather than bulk flow

  2017cited by this paper
• HPLC and TLC methods for analysis of [18F]FDG and its metabolites from biological samples.

  2017cited by this paper
• Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

  2017cited by this paper
• Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma

  2017cited by this paper
• Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype

  2017cited by this paper
• Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain

  2017cited by this paper
• Subtle blood‐brain barrier leakage rate and spatial extent: Considerations for dynamic contrast‐enhanced MRI

  2017cited by this paper
• Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease

  2017cited by this paper
• Band-like calcification with simplified gyration and polymicrogyria: report of 10 new families and identification of five novel OCLN mutations

  2017cited by this paper
• Advanced Neuroimaging of Cerebral Small Vessel Disease

  2017cited by this paper
• Alzheimer’s disease: A matter of blood–brain barrier dysfunction?

  2017cited by this paper
• CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.

  2017cited by this paper
• Neurovascular Alterations in Alzheimer’s Disease: Transporter Expression Profiles and CNS Drug Access

  2017cited by this paper
• Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.

  2017cited by this paper
• PO071 Mri assessment of neurovascular changes in idiopathic parkinson’s disease

  2017cited by this paper
• Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound

  2017cited by this paper
• Linking Amyloid-β and Tau Deposition in Alzheimer Disease.

  2017cited by this paper
• The movers and shapers in immune privilege of the CNS

  2017cited by this paper
• Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease

  2017cited by this paper
• Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease?

  2017cited by this paper
• Albumin and multiple sclerosis

  2016cited by this paper
• Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases

  2016cited by this paper
• Cerebral microbleeds in early Alzheimer’s disease

  2016cited by this paper
• Analysis of the brain mural cell transcriptome

  2016cited by this paper
• Glutamate-Mediated Blood–Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery

  2016cited by this paper
• Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease

  2016cited by this paper
• Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease.

  2016cited by this paper
• Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease

  2016cited by this paper
• Glymphatic solute transport does not require bulk flow

  2016cited by this paper
• Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease

  2016cited by this paper
• Spatial model of convective solute transport in brain extracellular space does not support a “glymphatic” mechanism

  2016cited by this paper
• A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid β -Peptide from the Brain.

  2016cited by this paper
• Interaction between cerebrovascular disease and Alzheimer pathology

  2016cited by this paper
• Pericytes of the neurovascular unit: key functions and signaling pathways

  2016cited by this paper
• Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier

  2016cited by this paper
• Blood–Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic Encephalopathy

  2016cited by this paper
• Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

  2016cited by this paper
• Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field.

  2016cited by this paper
• Microbubble-Assisted Ultrasound for Drug Delivery in the Brain and Central Nervous System.

  2016cited by this paper
• Vascular, glial, and lymphatic immune gateways of the central nervous system

  2016cited by this paper
• Cortical superficial siderosis

  2016cited by this paper
• Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood–brain barrier permeability using dynamic contrast‐enhanced MRI

  2016cited by this paper
• Annexin A1 restores Aβ1‐42‐induced blood–brain barrier disruption through the inhibition of RhoA‐ROCK signaling pathway

  2016cited by this paper
• Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

  2016cited by this paper
• Brain imaging of neurovascular dysfunction in Alzheimer’s disease

  2016cited by this paper
• Erratum: Clearance systems in the brain—implications for Alzheimer diseaser

  2016cited by this paper
• Relation of Cerebral Vessel Disease to Alzheimer’s Disease Dementia and Cognitive Function in Older Persons: A Cross-sectional Study

  2016cited by this paper
• Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging.

  2016cited by this paper
• A cross-sectional study

  2016cited by this paper
• Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy

  2016cited by this paper
• Increased CSF biomarkers of angiogenesis in Parkinson disease

  2016cited by this paper
• Restoration of Cerebral and Systemic Microvascular Architecture in APP/PS1 Transgenic Mice Following Treatment with Liraglutide™

  2015cited by this paper
• Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation.

  2015cited by this paper
• Establishment and Dysfunction of the Blood-Brain Barrier.

  2015cited by this paper
• Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease.

  2015cited by this paper
• GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

  2015cited by this paper
• The Glymphatic System: A Beginner’s Guide

  2015cited by this paper
• Targeted delivery of protein and gene medicines through the blood–brain barrier

  2015cited by this paper
• Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood—Brain Barrier and Provide Neuroprotection

  2015cited by this paper
• Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis

  2015cited by this paper
• Blood-brain barrier breakdown in the aging human hippocampus.

  2015cited by this paper
• Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance

  2015cited by this paper
• Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice

  2015cited by this paper
• ROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies

  2015cited by this paper
• Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation

  2015cited by this paper
• Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.

  2015cited by this paper
• Increased CSF biomarkers of angiogenesis in Parkinson disease

  2015cited by this paper
• Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin

  2015cited by this paper
• Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

  2015cited by this paper
• Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes.

  2015cited by this paper
• Structural and functional features of central nervous system lymphatics

  2015cited by this paper
• Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease

  2015cited by this paper
• Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome

  2015cited by this paper
• Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

  2015cited by this paper
• α-Synuclein strains cause distinct synucleinopathies after local and systemic administration

  2015cited by this paper
• Clearance systems in the brain—implications for Alzheimer disease

  2015cited by this paper
• Biologics: Transferrin' bispecific antibodies across the blood–brain barrier

  2015cited by this paper
• Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and 18F-FDG PET Quantitative Analysis Using FreeSurfer

  2015cited by this paper
• Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

  2015cited by this paper
• A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome

  2015cited by this paper
• Commentary: Structural and functional features of central nervous system lymphatic vessels

  2015cited by this paper
• Breaking boundaries—coagulation and fibrinolysis at the neurovascular interface

  2015cited by this paper
• Cerebral Microbleeds: Different Prevalence, Topography, and Risk Factors Depending on Dementia Diagnosis—The Karolinska Imaging Dementia Study

  2015cited by this paper
• A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans.

  2015cited by this paper
• Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

  2015cited by this paper
• ' s response to reviews Title : ROCKETSHIP : a flexible and modular software tool for the planning , processing and analysis of dynamic MRI studies

  2015cited by this paper
• Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier

  2015cited by this paper
• Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis

  2014cited by this paper
• Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

  2014cited by this paper
• Mutant huntingtin is present in neuronal grafts in huntington disease patients

  2014cited by this paper
• Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid

  2014cited by this paper
• Air Pollution and Children: Neural and Tight Junction Antibodies and Combustion Metals, the Role of Barrier Breakdown and Brain Immunity in Neurodegeneration

  2014cited by this paper
• Large arteriolar component of oxygen delivery implies safe margin of oxygen supply to cerebral tissue

  2014cited by this paper
• Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates

  2014cited by this paper
• Blood-Brain Barrier Permeability in Aging and Alzheimer's Disease.

  2014cited by this paper
• Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

  2014cited by this paper
• Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients

  2014cited by this paper
• Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice

  2014cited by this paper

• The Role of Unmethylated 5′-C-Phosphate-G-3′ (CpG) Motifs in Mitochondrial and Bacterial DNA in the Pathogenesis of Alzheimer’s Disease

  2026cites this paper
• Advances in Alzheimer's disease: mechanistic insights and therapeutic targets.

  2026cites this paper
• In Vitro Analysis of TWEAK/Fn14 Axis in the Blood–Brain Barrier Models during Oxygen–Glucose Deprivation and Reoxygenation

  2026cites this paper
• Effects of Low‐Intensity Ultrasound on Amyloid‐ β Clearance in Early‐Stage Alzheimer′s Disease: A Potential Role of Glymphatic Activity

  2026cites this paper
• A stimuli-responsive mitochondria-targeted nanoplatform for glioblastoma therapy: modulating the blood-brain barrier and delivering precise chemotherapy.

  2026cites this paper
• Functional border-associated macrophages limit Alzheimer’s Disease progression

  2026cites this paper
• Microvascular Failure in the Aging Brain: Converging Pathways of Oxidative Stress, Inflammation, and Endothelial Decline

  2026influential citation
• Inclisiran Attenuates Alzheimer's Disease-like Changes by Suppressing Microvascular Endothelial Ferroptosis to Preserve Blood-Brain Barrier Integrity.

  2026cites this paper
• Cobrotoxin mitigates neuroinflammation and cognitive impairment by suppressing CD8+ T cell-microglia interactions in male 5 × FAD mice.

  2026cites this paper
• Digging Deep into Alzheimer Disease: How Electron Microscopy Helps Elucidating Its Pathogenesis.

  2026cites this paper
• The Sweet Gatekeeper: Mucin-Type O-Glycans in Brain Endothelial Glycocalyx and Aging.

  2026cites this paper
• Surface-Engineered Precision Nano-Systems for Targeted Treatment of Huntington's Disease: A Review of Recent Advancements.

  2026cites this paper
• Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration.

  2026cites this paper
• Natural Anti-NMDAR1 autoantibodies associate with slowed decline of cognitive functions in Alzheimer’s diseases

  2026cites this paper
• Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model

  2026cites this paper
• Unraveling the Anti-Alzheimer's mechanisms of optimal constituent from Arisaema heterophyllum Blume through multi-model and phytochemical analysis.

  2026cites this paper
• Cerebral haemodynamics and white matter hyperintensities: findings using non-invasive brain imaging

  2026cites this paper
• Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer's disease.

  2026cites this paper
• Exploring the toxic mechanism of cypermethrin-induced neurodegeneration diseases via network toxicology and molecular docking

  2026cites this paper
• A KETOGENIC DIET PROMOTES BLOOD-SPINAL CORD BARRIER RESEALING AND PHENOTYPIC SWITCHING OF PRO-INFLAMMATORY MYELOID CELL INFILTRATES IN A PRECLINICAL MODEL OF MULTIPLE SCLEROSIS

  2026cites this paper
• Non-Neuronal Cell-Specific Death Pathways after Intracerebral Hemorrhage and Their Impact on the Blood-Brain Barrier and White Matter Structure

  2026cites this paper
• Maternal gut microbiota mediates prenatal stress-induced fetal blood‒brain barrier dysfunction.

  2026cites this paper
• Outcomes of modern total joint arthroplasty in patients with dementia: a systematic review of challenges and considerations for perioperative care

  2026cites this paper
• Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's disease - Mechanisms and therapeutic frontiers.

  2026cites this paper
• Obesity as a catalyst for neurodegeneration.

  2026cites this paper
• NOTCH3 Mutations in CADASIL: a multicellular perspective on neurodegeneration.

  2026cites this paper
• Identification of plasma inflammatory biomarkers for Alzheimer's disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype.

  2026cites this paper
• Association between repeated antibiotic prescribing and seizure- and other neuropsychiatric disorders-related hospitalization among people living with dementia: a population-based cohort study.

  2026cites this paper
• Integrated Single-Cell Multi-Omics Analysis Reveals That a CD8+ TPex-Monocyte Interaction Axis Coordinates Immune Infiltration in Alzheimer's Disease.

  2026cites this paper
• From Traumatic Brain Injury to Alzheimer’s Disease: Multilevel Biomechanical, Neurovascular, and Molecular Mechanisms with Emerging Therapeutic Directions

  2026cites this paper
• Bringing natural killer cells to the clinic: Opportunities beyond cancer.

  2026cites this paper
• Integrating the Blood–Brain Barrier and Blood-CSF Barrier Organ-on-Chip Models: Development and Future Directions

  2026cites this paper
• Rethinking on bile acid-brain axis: decoding neurotoxic and neuroprotective landscape in aging and Alzheimer’s disease

  2026cites this paper
• A multi-target therapeutic framework for Alzheimer's disease: an integrative mechanistic review.

  2026cites this paper
• Alternating Current-Driven Silver Needle-Based Electrochemiluminescence Biosensor for Rapid and Low-Damage Diagnosis of Cerebral Hemorrhage with Edema.

  2026cites this paper
• A Question of Origins: Non-neuronal Sources of Amyloid-β.

  2026cites this paper
• Histone and non-histone (de)acetylation impact on the blood-brain barrier

  2026cites this paper
• The RNA-Binding Protein MSI2 Controls Blood-Tumor Barrier Permeability via LINC00667-Mediated IRF6 mRNA Decay.

  2026cites this paper
• Angiogenic and anti-angiogenic factors are the shared mechanistic pathways between preeclampsia and Alzheimer's disease: Perspective and take-away.

  2026cites this paper
• Acute amyloid-β exposure disrupts insulin signaling in blood–brain barrier endothelial cell culture models

  2026cites this paper
• Ultrasound-Mediated Gene Therapy in Alzheimer’s Disease Validated through In Vivo PET Imaging

  2026cites this paper
• Neuroimmune Dysregulation in Alzheimer's Disease: Mechanisms and Therapeutic Strategies.

  2026cites this paper
• Tau is necessary for Pseudomonas aeruginosa-induced blood-brain barrier dysfunction.

  2026cites this paper
• Postoperative neurocognitive disorder: migration and crosstalk of inflammation in the peripheral and central nervous system.

  2026cites this paper
• Protective mutations associated with APOE in Alzheimer's disease.

  2026cites this paper
• PROTAC-Mediated Degradation of mHTT Aggregates Attenuates Neurotoxicity in Cellular and R6/2 Mouse Models of Huntington's Disease.

  2026cites this paper
• WS 2 Nanosheet Quenched Erbium Doped NaYF 4 Upconversion Immunoprobe for the Detection of Glial Fibrillary Acidic Protein: Prognostic Biomarker of Alzheimer's Disease in Serum

  2026cites this paper
• Assessment of Angiopep-2 targeting intracerebral α-synuclein aggregates in a PFF-induced rat model of Parkinson's disease based on 7T CEST-MRI.

  2026cites this paper
• Neuroinflammation as a driver of Down syndrome-associated Alzheimer's disease.

  2026cites this paper
• Prenatal caloric restriction reprograms endothelial transcriptional states and blood-brain barrier integrity: Implications for neurodevelopmental disorders.

  2026cites this paper
• Inflammation-Associated Mechanisms of Blood–Brain Barrier Disruption and Depression Pathogenesis in People with and Without HIV

  2026cites this paper
• Glycidol induces ferroptosis via the Nrf2/GPX4 pathway disrupting the blood-brain barrier and impairing neurological homeostasis

  2026cites this paper
• Effect and potential mechanism of photobiomodulation therapy on cognitive deficits in animal models of Alzheimer's disease: a systematic review and meta-analysis.

  2026cites this paper
• Recapitulating Alzheimer's disease pathophysiology with a microfluidic neurospheroid-grafted endothelial barrier model.

  2026cites this paper
• Glioinflammation: disease-associated microglia and astrocytes in psychiatric disorders, neurodegeneration, and senescence.

  2026cites this paper
• Higher sodium intake is associated with episodic memory decline in cognitively unimpaired older males: A 6-year longitudinal study.

  2026cites this paper
• Liver exerkine reverses aging- and Alzheimer's-related memory loss via vasculature.

  2026cites this paper
• miR126-mediated alteration of vascular integrity in Rett syndrome.

  2026cites this paper
• Network-based prediction and real-world patient data observation identify doxycycline as a repurposable drug in Alzheimer's disease.

  2026cites this paper
• Immunometabolism Reframes Alzheimer’s Disease: From Systemic Dysmetabolism to Glial Rewiring

  2026influential citation
• Silencer variants are key drivers of gene up-regulation in Alzheimer’s disease

  2026cites this paper
• A Pathophysiological Model of Parkinson's Disease Based on Microvascular Flow Disturbance and Leukocyte-Mediated Oxidative Injury in Critical Pigmented Neuronal Niches.

  2026cites this paper
• Three-dimensional human brain organoids: A next-generation model to decode Alzheimer’s disease

  2026cites this paper
• Impedance detection of 3D blood-brain barrier organoids based on an interdigitated electrode

  2026cites this paper
• Intranasal dabigatran etexilate lipid nanoparticles: A targeted approach for management of Alzheimer's disease

  2026cites this paper
• Mechanisms of Panax notoginseng in the treatment of vascular disease: A review and preliminary analysis

  2026cites this paper
• Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD mice

  2026cites this paper
• From Nose to Neurons: The Emerging Role of Dissolving Microneedles in Neurodegenerative Disease Management

  2026cites this paper
• CHI3L1 monoclonal antibody therapy mitigates cognitive impairment by inhibiting neuroinflammation through ERK and NF-κB pathway in Tg2576 mice

  2026cites this paper
• The aging gut-glia-immune axis in alzheimer's disease: microbiome-derived mediators of neuroinflammation and therapeutic innovation.

  2026cites this paper
• Electrical stimulation of the vagus nerve improves amyloid pathology in delirium superimposed on dementia

  2026cites this paper
• The Function of Microglia in Cognitive Impairment Influenced by Sleep Deprivation

  2026cites this paper
• Pharmacological modulation of the blood-brain barrier: Mechanisms, therapeutic strategies, and emerging technologies.

  2026cites this paper
• Infection trajectories and dementia risk in type 2 diabetes

  2026cites this paper
• Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer’s Disease

  2026cites this paper
• Brain capillary endothelial-like cells show altered barrier functionality and reduced transport of amyloid β in late-onset Alzheimer disease

  2026cites this paper
• Postbiotics and the gut-brain axis: A mechanistic review on modulating neuroinflammation and cognitive aging.

  2026cites this paper
• Exploring Green-Synthesized Silver Nanoparticles in Neurodegeneration: a Systematic Review of Cholinesterase Enzyme Interactions

  2026cites this paper
• The C3–C3aR axis drives rotenone-induced cognitive damage via synaptic engulfment, dark microglia and PANoptosis

  2026cites this paper
• Microglial, astrocytic, oligodendrocyte, B-/T-cell and neutrophil dysregulation in neuroinflammation of Alzheimer's disease and related dementias.

  2026cites this paper
• APP‐mediated intracellular signaling rescues sleep impairment and blood–brain barrier leakage in Alzheimer's disease mouse model

  2026cites this paper
• Translation of hyperpolarized [13C,15N2]urea MRI for novel human brain perfusion studies

  2025cites this paper
• Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of Alzheimer's disease.

  2025cites this paper
• Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders.

  2025cites this paper
• Research developments in the neurovascular unit and the blood‑brain barrier (Review)

  2025cites this paper
• CD2AP in Alzheimer's disease: Key mechanisms and therapeutic potential

  2025cites this paper
• Cerebromicrovascular senescence in vascular cognitive impairment: does accelerated microvascular aging accompany atherosclerosis?

  2025cites this paper
• Caveolae-Mediated Transcytosis and Its Role in Neurological Disorders

  2025cites this paper
• Vascular and glymphatic dysfunction as drivers of cognitive impairment in Alzheimer's disease: Insights from computational approaches.

  2025cites this paper
• Endothelial TDP-43 depletion disrupts core blood–brain barrier pathways in neurodegeneration

  2025cites this paper
• Ultrasound-responsive nanoparticles for imaging and therapy of brain tumors

  2025cites this paper
• Role of FPR2 antagonism in alleviating social isolation-induced depression and protecting blood-brain barrier integrity

  2025cites this paper
• The role of the intestinal microbiome in cognitive decline in patients with kidney disease

  2025cites this paper
• Systematic Identification of Mitochondrial Signatures in Alzheimer’s Disease and Inflammatory Bowel Disease

  2025cites this paper
• Amyloid-β-regulated gene circuits for programmable Alzheimer’s disease therapy

  2025cites this paper
• An imaging and genetic-based deep learning network for Alzheimer's disease diagnosis

  2025cites this paper
• Therapeutic Approaches and Potential Mechanisms of Small Extracellular Vesicles in Treating Vascular Dementia

  2025cites this paper
• Impact of Peripheral Inflammation on Blood–Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases

  2025cites this paper
• Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier.

  2025cites this paper
• SSAO-mediated decrease of endothelial BDNF release affects neuronal GluA1 and PSD95 expression: a peripheral mechanism inducing NVU and CNS disturbances

  2025cites this paper